Today: 21 May 2026
AppLovin stock rises as Wall Street resets targets — what traders are watching next
13 January 2026
1 min read

AppLovin stock rises as Wall Street resets targets — what traders are watching next

New York, January 13, 2026, 11:12 AM (ET) — Market open

AppLovin shares rose roughly 0.5% Tuesday, recovering after a volatile start as investors digested new price targets from brokers on the ad-tech firm.

Timing is crucial. Since the start of the year, AppLovin has behaved like a momentum play, and even slight shifts in sell-side sentiment can sway the stock when positioning is tight and expectations run high.

At 11:12 a.m. ET, the stock changed hands at $662.24, having fluctuated from a low of $643.00 to a high of $666.57. The wider market edged lower, with the S&P 500 ETF slipping around 0.2% and the Nasdaq 100 ETF also down about 0.2%.

Morgan Stanley bumped up its price target on AppLovin to $800 from $750, maintaining an “overweight” rating. Meanwhile, Goldman Sachs shaved its target slightly to $710 from $720 but stuck with a “neutral” stance, according to MT Newswires reports carried by MarketScreener. (A price target estimates where a stock might trade; “overweight” suggests expectations to beat peers.) MarketScreener data shows 27 analysts cover AppLovin, with an average target near $742 and a consensus “buy.” MarketScreener

The stock closed Monday at $658.65, marking a 1.69% gain for the day, according to historical pricing data.

AppLovin provides software that enables advertisers to purchase and track ads while helping app publishers monetize their users. The company is pivoting more toward advertising technology after agreeing to sell its mobile games studio portfolio to Tripledot Studios for roughly $800 million in cash and stock. This deal puts more focus on its marketing platform.

Still, the stock isn’t without headline risk. AppLovin has been under the microscope for its data-collection methods. Back in October, Reuters reported the U.S. SEC was investigating the company’s practices, citing sources familiar with the matter. It’s unclear how far along that review is. Any regulatory action, a shift in platform rules, or renewed interest from short sellers could quickly sour sentiment in a stock priced for growth.

AppLovin is set to drop its quarterly numbers next. The company plans to unveil its fourth-quarter and full-year 2025 results on Feb. 11, after U.S. markets shut. A management webcast will follow at 5:00 p.m. ET.

Stock Market Today

  • CyberTech Systems Earnings Raise Cash Flow Concerns Amid Market Stability
    May 20, 2026, 8:56 PM EDT. CyberTech Systems and Software Limited (NSE:CYBERTECH) posted earnings that met market expectations but revealed an accrual ratio of 0.53, indicating weaker free cash flow relative to profit. This financial metric, which measures non-cash earnings, signals potential challenges for upcoming profits as free cash flow of ₹76 million lagged behind reported profit of ₹304.3 million for the year ending March 2026. Despite a 28% annual growth in earnings per share (EPS) over three years, the decline in cash conversion may raise investor caution. The company's accrual ratio improved last year, suggesting the current shortfall could be temporary, but shareholders are advised to monitor cash flow trends closely against profitability for a clearer outlook.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Dow Jones today: DJIA slips from record as Visa and banks weigh after CPI
Previous Story

Dow Jones today: DJIA slips from record as Visa and banks weigh after CPI

SOLS stock jumps as Solstice Advanced Materials targets $220 million Virginia ballistic-fiber buildout
Next Story

SOLS stock jumps as Solstice Advanced Materials targets $220 million Virginia ballistic-fiber buildout

Go toTop